FIRALIS S.A.
Edit

FIRALIS S.A.

http://firalis.com/
Tags:BioTechDevelopmentDiagnosticsDrugHealthTechIndustryMedtechPlatformServiceTools
Firalis is a biotechnology company with an acknowledged leadership and expertise in the field of biomarkers (BM), in particular within the cardiovascular field. Firalis develops and markets biomarkers and biomarker-based diagnostic tools such as ELISA assay kits, for pre-clinical and clinical applications, including: • Safety BMs for drug-induced cardiovascular injuries • Diagnostic/prognostic BMs for vasculitis and myocardial infarction • Theranostic and companion BMs for CV related drugs Firalis owes its leading position to below major advantages: • Pioneer expertise in the development and "clinical qualification" of new innovative biomarkers • A large, well-established network of international centers of excellence, large biobank initiatives, acknowledged clinicians, major players from pharmaceutical industry and several private biotech companies (SMEs) that are working in complementary fields. • A unique IP position on biomarkers of drug-induced cardiovascular safety. • ISO:9001 and ISO:13485 certified laboratories • ISO:17025 accredited testing activities • An established GLP/GCLP & NF S96-900 compliant work environment for biomarker assay development and testing activities • A robust technology platform, including multiplex arrays Follow us on: Linkedin : www.linkedin.com/company/firalis-sas Twitter : https://twitter.com/FiralisGroup
Likes
101
Location: France, Grand Est, Huningue
Member count: 11-50
Phone: +33 3 89 91 13 20
Founded date: 2008